KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Inventory (2016 - 2025)

Repligen (RGEN) has disclosed Inventory for 15 consecutive years, with $170.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory rose 19.23% to $170.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $170.5 million, a 19.23% increase, with the full-year FY2025 number at $170.5 million, up 19.23% from a year prior.
  • Inventory was $170.5 million for Q4 2025 at Repligen, up from $143.0 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $244.7 million in Q1 2023 to a low of $109.5 million in Q1 2021.
  • A 5-year average of $194.0 million and a median of $198.0 million in 2024 define the central range for Inventory.
  • Peak YoY movement for Inventory: skyrocketed 98.86% in 2021, then dropped 29.34% in 2024.
  • Repligen's Inventory stood at $184.5 million in 2021, then rose by 29.15% to $238.3 million in 2022, then dropped by 15.09% to $202.3 million in 2023, then decreased by 29.34% to $143.0 million in 2024, then rose by 19.23% to $170.5 million in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Inventory are $170.5 million (Q4 2025), $143.0 million (Q4 2024), and $190.5 million (Q2 2024).